tiprankstipranks
Vanda Pharmaceuticals (VNDA)
NASDAQ:VNDA
US Market
VNDA
Vanda
RESEARCH TOOLSreports
Want to see VNDA full AI Analyst Report?

Vanda (VNDA) Stock News & Sentiment

670 Followers
Vanda Pharmaceuticals Bets Big on Growth Pipeline
Premium
Company Announcements
Vanda Pharmaceuticals Bets Big on Growth Pipeline
16d ago
VNDA
VNDA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
VNDA Earnings this Week: How Will it Perform?
20d ago
VNDA
Vanda Pharmaceuticals Adds Independent Director to Strengthen Board
Premium
Company Announcements
Vanda Pharmaceuticals Adds Independent Director to Strengthen Board
1M ago
8K
VNDA
Vanda Pharmaceuticals: Undervalued GLP-1 Adjunct Opportunity Driven by Tradipitant’s Pivotal Thetis Trial
Premium
Ratings
Vanda Pharmaceuticals: Undervalued GLP-1 Adjunct Opportunity Driven by Tradipitant’s Pivotal Thetis Trial
1M ago
VNDA
Vanda Announces Resignation of Senior Legal Executive
Premium
Company Announcements
Vanda Announces Resignation of Senior Legal Executive
2M ago
8K
VNDA
Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy
Premium
Company Announcements
Vanda Advances NEREUS Launch With Direct-to-Consumer Strategy
2M ago
8K
VNDA
Vanda Pharmaceuticals: Limited Downside, Pipeline-Driven Upside Supports $24 Target Price
Premium
Ratings
Vanda Pharmaceuticals: Limited Downside, Pipeline-Driven Upside Supports $24 Target Price
3M ago
VNDA
More VNDA News >

VNDA News on the Web

STATE STREET CORP Increases Stake in Vanda Pharmaceuticals Inc
GuruFocus News
Bullish
Vanda Pharmaceuticals price target lowered to $21 from $24 at H.C. Wainwright
TipRanks News
Bearish
Vanda Pharmaceuticals Bets Big on Growth Pipeline
TipRanks News
Neutral
Truist Financial Sticks to Its Buy Rating for Vanda (VNDA)
TipRanks News
Neutral
Vanda Pharmaceuticals reports Q1 EPS (82c) vs. (50c) last year
TipRanks News
Bullish
Vanda Pharmaceuticals raises FY26 revenue view to $240M-$290M from $230-$260M
TipRanks News
Neutral
Vanda Pharmaceuticals announces U.S. commercial availability of Nereus
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: Fulcrum Therapeutics (FULC), Dexcom (DXCM) and Vanda (VNDA)
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
VNDA
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is VNDA’s Media Buzz Sentiment?
1 articles about VNDA were published this week. In an average week, 3.5 articles are published.
    What is VNDA’s weekly average amount of articles?
    In an average week, 3.5 articles about VNDA are published.
      What is VNDA’s News Sentiment?
      100% of articles about VNDA were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        ROIVRoivant Sciences
        ILAIsland Pharmaceuticals Ltd
        TLSATiziana Life Sciences
        Showing the stocks with the most bullish news sentiment over the past week